Emotional debate marks FDA hearing on Avastin

Breast cancer survivors and doctors make heated arguments in front of the FDA as the panel decides the fate of Avastin - a breast cancer drug that costs $88 thousand a year for treatment. NBC's Robert Bazell.June 28, 2011